Shanghai Kaibao Pharmaceutical Co Ltd banner

Shanghai Kaibao Pharmaceutical Co Ltd
SZSE:300039

Watchlist Manager
Shanghai Kaibao Pharmaceutical Co Ltd Logo
Shanghai Kaibao Pharmaceutical Co Ltd
SZSE:300039
Watchlist
Price: 5.6 CNY 5.86% Market Closed
Market Cap: ¥5.9B

Wall St Price Targets

Price Targets Summary
Shanghai Kaibao Pharmaceutical Co Ltd

There are no price targets for Shanghai Kaibao Pharmaceutical Co Ltd.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Shanghai Kaibao Pharmaceutical Co Ltd Competitors:
Price Targets
8155
Allied Circuit Co Ltd
-19% Downside

Revenue
Forecast

0% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
0% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 9 years is 3%.

Gross Profit
Forecast

0% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
0% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 10 years is 4%.

Operating Income
Forecast

1% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
1% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 10 years is 4%.

Pre-Tax Income
Forecast

1% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
1% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 9 years is 1%.

Net Income
Forecast

1% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
1% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 9 years is 1%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Shanghai Kaibao Pharmaceutical Co Ltd's stock price target?
Not Available

Shanghai Kaibao Pharmaceutical Co Ltd does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Shanghai Kaibao Pharmaceutical Co Ltd?
Projected CAGR
3%

Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 9 years is 3%.

What is the Gross Profit forecast for Shanghai Kaibao Pharmaceutical Co Ltd?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 10 years is 4%.

What is the Operating Income forecast for Shanghai Kaibao Pharmaceutical Co Ltd?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 10 years is 4%.

What is the Pre-Tax Income forecast for Shanghai Kaibao Pharmaceutical Co Ltd?
Projected CAGR
1%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 9 years is 1%.

What is the Net Income forecast for Shanghai Kaibao Pharmaceutical Co Ltd?
Projected CAGR
1%

Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 9 years is 1%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett